Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic alterations in patients with sensorineural hearing disorders

D Mayot1, M C Béné, K Dron

  • 1Clinique ORL B, CHRU Nancy-Brabois, Vandoeuvre les Nancy, France.

Clinical Immunology and Immunopathology
|July 1, 1993
PubMed
Summary

This study reveals immune system abnormalities in both sudden and progressive hearing loss. Sudden deafness showed depleted lymphocytes, while both types exhibited anti-cochlear antibodies, suggesting autoimmune involvement.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project.

ESMO open·2024
Same author

Improved nationwide survival of sarcoma patients with a network of reference centers.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.

European journal of cancer (Oxford, England : 1990)·2023
Same author

Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.

European journal of cancer (Oxford, England : 1990)·2023
Same author

Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study.

ESMO open·2023

Area of Science:

  • Immunology
  • Otolaryngology
  • Autoimmune Diseases

Background:

  • Autoimmune mechanisms are suspected in some hearing loss cases, with steroid therapy showing clinical efficacy.
  • Immune complexes, autoantibodies targeting the inner ear, and cellular effectors are implicated in autoimmune hearing loss.

Purpose of the Study:

  • To investigate immune system differences in patients with sudden deafness versus progressive sensorineural hearing impairment.
  • To identify specific autoantibodies and lymphocyte profiles associated with different forms of hearing loss.

Main Methods:

  • Studied 57 individuals: 17 with sudden deafness (Group 1) and 40 with progressive sensorineural hearing impairment (Group 2).
  • Analyzed peripheral lymphocyte subsets (CD3+, CD4+, CD8+) and autoantibodies (anti-nuclear, anti-thyroid, anti-cochlear, anti-cartilage).

Related Experiment Videos

Main Results:

  • Group 1 (sudden deafness) showed severe depletion of CD3+ and CD4+ lymphocytes.
  • Both groups exhibited a decrease in CD8+ cells.
  • Anti-cochlear antibodies were prevalent in both groups (75% in Group 1, 71% in Group 2).
  • Group 2 (progressive impairment) frequently presented with anti-nuclear and anti-thyroid antibodies.

Conclusions:

  • Distinct immune disorders may underlie sudden versus progressive deafness.
  • Both sudden and progressive sensorineural hearing impairment involve immune system abnormalities.
  • The presence of anti-cochlear antibodies in both groups suggests a common autoimmune component in hearing loss.